Literature DB >> 10572076

The insulin-like growth factor system in normal and malignant hematopoietic cells.

W Zumkeller1, S Burdach.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10572076

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Authors:  Naval Daver; Yanis Boumber; Hagop Kantarjian; Farhad Ravandi; Jorge Cortes; Michael E Rytting; Jitesh D Kawedia; Jordan Basnett; Kirk S Culotta; Zhihong Zeng; Hongbo Lu; Mary Ann Richie; Rebecca Garris; Lianchun Xiao; Wenbin Liu; Keith A Baggerly; Elias Jabbour; Susan O'Brien; Jan Burger; Linda J Bendall; Deborah Thomas; Marina Konopleva
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

Review 2.  Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis.

Authors:  L Benetatos; G Vartholomatos
Journal:  Leukemia       Date:  2015-02-23       Impact factor: 11.528

3.  Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.

Authors:  Yu-Waye Chu; Sabrina Schmitz; Baishakhi Choudhury; William Telford; Veena Kapoor; Susan Garfield; David Howe; Ronald E Gress
Journal:  Blood       Date:  2008-07-24       Impact factor: 22.113

4.  Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium.

Authors:  Elizabeth Milne; Kathryn R Greenop; Catherine Metayer; Joachim Schüz; Eleni Petridou; Maria S Pombo-de-Oliveira; Claire Infante-Rivard; Eve Roman; John D Dockerty; Logan G Spector; Sérgio Koifman; Laurent Orsi; Jérémie Rudant; Nick Dessypris; Jill Simpson; Tracy Lightfoot; Peter Kaatsch; Margarita Baka; Alessandra Faro; Bruce K Armstrong; Jacqueline Clavel; Patricia A Buffler
Journal:  Int J Cancer       Date:  2013-08-01       Impact factor: 7.396

Review 5.  Parental imprinting regulates insulin-like growth factor signaling: a Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis.

Authors:  M Z Ratajczak; D-M Shin; G Schneider; J Ratajczak; M Kucia
Journal:  Leukemia       Date:  2012-11-08       Impact factor: 11.528

6.  IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  Paula de Melo Campos; João A Machado-Neto; Christopher A Eide; Samantha L Savage; Renata Scopim-Ribeiro; Adriana da Silva Souza Duarte; Patricia Favaro; Irene Lorand-Metze; Fernando F Costa; Cristina E Tognon; Brian J Druker; Sara T Olalla Saad; Fabiola Traina
Journal:  Oncotarget       Date:  2016-02-09

7.  Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR.

Authors:  Qi He; Chun-Kang Chang; Feng Xu; Qing-Xia Zhang; Wen-Hui Shi; Xiao Li
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

8.  Single- and Bayesian Multi-Marker Genome-Wide Association for Haematological Parameters in Pigs.

Authors:  Siriluck Ponsuksili; Henry Reyer; Nares Trakooljul; Eduard Murani; Klaus Wimmers
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

9.  PBX1 is dispensable for neural commitment of RA-treated murine ES cells.

Authors:  Anne S Jürgens; Mateusz Kolanczyk; Dietrich C C Moebest; Tomasz Zemojtel; Urs Lichtenauer; Marlena Duchniewicz; Melanie P Gantert; Jochen Hecht; Uwe Hattenhorst; Stefan Burdach; Annette Dorn; Mark P Kamps; Felix Beuschlein; Daniel Räpple; Jürgen S Scheele
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-16       Impact factor: 2.416

10.  Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6.

Authors:  Helen K W Law; Wenwei Tu; Enmei Liu; Yu Lung Lau
Journal:  BMC Immunol       Date:  2008-12-17       Impact factor: 3.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.